Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PER2 | O15055 | 1/20 | 0.31 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.31 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL28358042 | 0.92 | CNR1 (0.34) | CNR1CNR2SLC6A9LMNAMAPT | |
| SCHEMBL7047205 | 0.82 | L3MBTL1 (0.37) | SLC6A9LMNAMEN1ALDH1A1KMT2A | |
| SCHEMBL5142659 | 0.81 | CNR1 (0.33) | CNR1CNR2SLC6A9MAPTALDH1A1 | |
| SCHEMBL18199163 | 0.78 | SLC6A9 (0.38) | SLC6A9PIK3CD | |
| SCHEMBL13416610 | 0.78 | SLC6A9 (0.38) | SLC6A9PIK3CD | |
| SCHEMBL9340450 | 0.77 | S1PR1 (0.40) | TSHR | |
| SCHEMBL31474253 | 0.76 | L3MBTL1 (0.41) | MEN1ALDH1A1KMT2A | |
| SCHEMBL9044432 | 0.74 | SLC6A1 (0.32) | — | |
| SCHEMBL23374594 | 0.74 | LMNA (0.46) | LMNAMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL23374635 | 0.74 | LMNA (0.46) | LMNAMAPTMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210338539-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC | 2021-11-04 | — | — | US | claimed |
| EP-3852716-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020061556-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2020-03-26 | — | — | WO | claimed |
| EP-1337146-B1 | AEROSOL INSECT REPELLENT COMPOSITION HAVING LOW VOC CONTENT AND METHOD OF APPLYING SAME TO THE SKIN | AVON PROD INC (US) | 2006-02-08 | — | — | EP | claimed |
| WO-2002043491-A9 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PROD INC (US) | 2003-08-14 | — | — | WO | claimed |
| EP-1250043-A4 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PROD INC (US) | 2003-04-02 | — | — | EP | claimed |
| EP-1250043-A1 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PRODUCTS, INC. (US) | 2002-10-23 | — | — | EP | claimed |
| WO-2002043491-A1 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PRODUCTS, INC. (US) | 2002-06-06 | — | — | WO | claimed |
| US-20230293406-A1 | Compositions Comprising (Bio)-Alkanediols and Cooling Agents | SYMRISE AG (DE) | 2023-09-21 | — | — | US | disclosed |
| US-20230248626-A1 | Compositions Comprising (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20210338539-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC | 2021-11-04 | — | — | US | disclosed |
| EP-1978803-B1 | INSECT REPELLENT COMPOSITION | DARLING SAMUEL T (CA) | 2016-04-06 | — | — | EP | disclosed |
| US-8501205-B2 | Insect repellent composition | NO MO FOUNDATION | 2013-08-06 | — | — | US | disclosed |
| US-20110183017-A1 | INSECT REPELLENT COMPOSITION | NO MO FOUNDATION | 2011-07-28 | — | — | US | disclosed |
| US-7846464-B2 | Insect repellent composition | NO MO FOUNDATION | 2010-12-07 | — | — | US | disclosed |
| EP-1978803-A2 | INSECT REPELLENT COMPOSITION | Darling, Samuel T. (CA) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007082306-A2 | INSECT REPELLENT COMPOSITION | DARLING SAMUEL T (CA) | 2007-07-19 | — | — | WO | disclosed |
| US-20070166342-A1 | INSECT REPELLENT COMPOSITION | NO MO FOUNDATION | 2007-07-19 | — | — | US | disclosed |
| WO-2007011586-A1 | HALLOYSITE MICROTUBULE PROCESSES, STRUCTURES, AND COMPOSITIONS | TECHNOLOGY INNOVATIONS, LLC (US) | 2007-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248626-A1 | Compositions Comprising (Bio)-Alkanediols | OR51E2, OR10J3, TRPA1 | CNR1 633/4885CNR2 278/4885SLC6A9 4429/4885 |
| US-20110183017-A1 | INSECT REPELLENT COMPOSITION | TRPM8, TRPV3, LSM8 | CNR1 752/4885CNR2 806/4885SLC6A9 1824/4885 |
| US-20070166342-A1 | INSECT REPELLENT COMPOSITION | TRPM8, TRPV3, LSM8 | CNR1 752/4885CNR2 806/4885SLC6A9 1824/4885 |
| US-20230293406-A1 | Compositions Comprising (Bio)-Alkanediols and Cooling Agents | OR51E2, MAL2, ADH1C | CNR1 854/4885CNR2 328/4885SLC6A9 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.